Status:
UNKNOWN
Implication of CD35, CD21 and CD55 in Exudative Age-related Macular Degeneration
Lead Sponsor:
Rudolf Foundation Clinic
Conditions:
Age-Related Macular Degeneration
Eligibility:
All Genders
55+ years
Brief Summary
The purpose of this study is to determine a possible implication of CD21, CD35 and CD55 in the pathogenesis of age-related macular degeneration. The aim is to asses a difference in expression rates of...
Eligibility Criteria
Inclusion
- Man and women over 18 years old
- Filled out informed consent
- Diagnosis of non-exudative/ exudative age related macular degeneneration
Exclusion
- Inherited retinal diseases
- Other acquired retinal/ macular
- Missing informed consent
Key Trial Info
Start Date :
September 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 1 2010
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT01174407
Start Date
September 1 2008
End Date
August 1 2010
Last Update
August 3 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rudolf Foundation Clinic
Vienna, Vienna, Austria, 1030